A BILL 
To direct the Secretary of Veterans Affairs to conduct an 
independent review of the deaths of certain veterans by 
suicide, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Veteran Overmedica-
4
tion and Suicide Prevention Act of 2021’’. 
5
SEC. 
2. 
DEPARTMENT 
OF 
VETERANS 
AFFAIRS 
INDE-
6
PENDENT REVIEW OF CERTAIN DEATHS OF 
7
VETERANS BY SUICIDE. 
8
(a) REVIEW REQUIRED.— 
9
23:56 Jan 20, 2021
H67
2 
•HR 67 IH
(1) IN GENERAL.—Not later than 90 days after 
1
the date of the enactment of this Act, the Secretary 
2
of Veterans Affairs shall seek to enter into an agree-
3
ment with the National Academies of Sciences, En-
4
gineering, and Medicine under which the National 
5
Academies shall conduct a review of the deaths of all 
6
covered veterans who died by suicide during the five- 
7
year period ending on the date of the enactment of 
8
this Act, regardless of whether information relating 
9
to such deaths has been reported by the Centers for 
10
Disease Control and Prevention. 
11
(2) ELEMENTS.—The review required by para-
12
graph (1) shall include the following: 
13
(A) The total number of covered veterans 
14
who died by suicide during the five-year period 
15
ending on the date of the enactment of this Act. 
16
(B) The total number of covered veterans 
17
who died by a violent death during such five- 
18
year period. 
19
(C) The total number of covered veterans 
20
who died by an accidental death during such 
21
five-year period. 
22
(D) A description of each covered veteran 
23
described in subparagraphs (A) through (C), in-
24
cluding age, gender, race, and ethnicity. 
25
23:56 Jan 20, 2021
H67
3 
•HR 67 IH
(E) A comprehensive list of prescribed 
1
medications and legal or illegal substances as 
2
annotated on toxicology reports of covered vet-
3
erans described in subparagraphs (A) through 
4
(C), specifically listing any medications that 
5
carried a black box warning, were prescribed for 
6
off-label use, were psychotropic, or carried 
7
warnings that included suicidal ideation. 
8
(F) A summary of medical diagnoses by 
9
physicians of the Department of Veterans Af-
10
fairs or physicians providing services to covered 
11
veterans through programs of the Department 
12
that led to the prescribing of medications re-
13
ferred to in subparagraph (E) in cases of post- 
14
traumatic stress disorder, traumatic brain in-
15
jury, military sexual trauma, and other anxiety 
16
and depressive disorders. 
17
(G) The number of instances in which a 
18
covered veteran described in subparagraph (A), 
19
(B), or (C) was concurrently on multiple medi-
20
cations prescribed by physicians of the Depart-
21
ment or physicians providing services to vet-
22
erans through programs of the Department to 
23
treat post-traumatic stress disorder, traumatic 
24
brain injury, military sexual trauma, other anx-
25
23:56 Jan 20, 2021
H67
4 
•HR 67 IH
iety and depressive disorders, or instances of 
1
comorbidity. 
2
(H) The number of covered veterans de-
3
scribed in subparagraphs (A) through (C) who 
4
were not taking any medication prescribed by a 
5
physician of the Department or a physician pro-
6
viding services to veterans through a program 
7
of the Department. 
8
(I) With respect to the treatment of post- 
9
traumatic stress disorder, traumatic brain in-
10
jury, military sexual trauma, or other anxiety 
11
and depressive disorders, the percentage of cov-
12
ered veterans described in subparagraphs (A) 
13
through (C) who received a non-medication 
14
first-line treatment compared to the percentage 
15
of such veterans who received medication only. 
16
(J) With respect to the treatment of cov-
17
ered veterans described in subparagraphs (A) 
18
through (C) for post-traumatic stress disorder, 
19
traumatic brain injury, military sexual trauma, 
20
or other anxiety and depressive disorders, the 
21
number of instances in which a non-medication 
22
first-line treatment (such as cognitive behav-
23
ioral therapy) was attempted and determined to 
24
be ineffective for such a veteran, which subse-
25
23:56 Jan 20, 2021
H67
5 
•HR 67 IH
quently led to the prescribing of a medication 
1
referred to in subparagraph (E). 
2
(K) A description and example of how the 
3
Department determines and continually updates 
4
the clinical practice guidelines governing the 
5
prescribing of medications. 
6
(L) An analysis of the use by the Depart-
7
ment, including protocols or practices at med-
8
ical facilities of the Department, of systemati-
9
cally measuring pain scores during clinical en-
10
counters under the Pain as the 5th Vital Sign 
11
Toolkit of the Department and an evaluation of 
12
the relationship between the use of such meas-
13
urements and the number of veterans concur-
14
rently on multiple medications prescribed by 
15
physicians of the Department. 
16
(M) A description of the efforts of the De-
17
partment to maintain appropriate staffing levels 
18
for mental health professionals, such as mental 
19
health counselors, marriage and family thera-
20
pists, and other appropriate counselors, includ-
21
ing— 
22
(i) a description of any impediments 
23
to carry out the education, training, and 
24
hiring of mental health counselors and 
25
23:56 Jan 20, 2021
H67
6 
•HR 67 IH
marriage and family therapists under sec-
1
tion 7302(a) of title 38, United States 
2
Code, and strategies for addressing those 
3
impediments; 
4
(ii) a description of the objectives, 
5
goals, and timing of the Department with 
6
respect to increasing the representation of 
7
such counselors and therapists in the be-
8
havioral health workforce of the Depart-
9
ment, including— 
10
(I) a review of eligibility criteria 
11
for such counselors and therapists and 
12
a comparison of such criteria to that 
13
of other behavioral health professions 
14
in the Department; and 
15
(II) an assessment of the partici-
16
pation of such counselors and thera-
17
pists in the mental health profes-
18
sionals trainee program of the De-
19
partment and any impediments to 
20
such participation; 
21
(iii) an assessment of the development 
22
by the Department of hiring guidelines for 
23
mental health counselors, marriage and 
24
23:56 Jan 20, 2021
H67
7 
•HR 67 IH
family therapists, and other appropriate 
1
counselors; 
2
(iv) a description of how the Depart-
3
ment— 
4
(I) identifies gaps in the supply 
5
of mental health professionals; and 
6
(II) determines successful staff-
7
ing ratios for mental health profes-
8
sionals of the Department; 
9
(v) a description of actions taken by 
10
the Secretary, in consultation with the Di-
11
rector of the Office of Personnel Manage-
12
ment, to create an occupational series for 
13
mental health counselors and marriage and 
14
family therapists of the Department and a 
15
timeline for the creation of such an occu-
16
pational series; and 
17
(vi) a description of actions taken by 
18
the Secretary to ensure that the national, 
19
regional, and local professional standards 
20
boards for mental health counselors and 
21
marriage and family therapists are com-
22
prised of only mental health counselors and 
23
marriage and family therapists and that 
24
the liaison from the Department to such 
25
23:56 Jan 20, 2021
H67
8 
•HR 67 IH
boards is a mental health counselor or 
1
marriage and family therapist. 
2
(N) The percentage of covered veterans de-
3
scribed in subparagraphs (A) through (C) with 
4
combat experience or trauma related to combat 
5
experience (including military sexual trauma, 
6
traumatic brain injury, and post-traumatic 
7
stress). 
8
(O) An identification of the medical facili-
9
ties of the Department with markedly high pre-
10
scription rates and suicide rates for veterans re-
11
ceiving treatment at those facilities. 
12
(P) An analysis, by State, of programs of 
13
the Department that collaborate with State 
14
Medicaid agencies and the Centers for Medicare 
15
and Medicaid Services, including the following: 
16
(i) An analysis of the sharing of pre-
17
scription and behavioral health data for 
18
veterans. 
19
(ii) An analysis of whether Depart-
20
ment staff check with State prescription 
21
drug monitoring programs before pre-
22
scribing medications to veterans. 
23
(iii) A description of the procedures of 
24
the Department for coordinating with pre-
25
23:56 Jan 20, 2021
H67
9 
•HR 67 IH
scribers outside of the Department to en-
1
sure that veterans are not overprescribed. 
2
(iv) A description of actions that the 
3
Department takes when a veteran is deter-
4
mined to be overprescribed. 
5
(Q) An analysis of the collaboration of 
6
medical centers of the Department with medical 
7
examiners’ offices or local jurisdictions to deter-
8
mine veteran mortality and cause of death. 
9
(R) An identification and determination of 
10
a best practice model to collect and share vet-
11
eran death certificate data between the Depart-
12
ment of Veterans Affairs, the Department of 
13
Defense, States, and tribal entities. 
14
(S) A description of how data relating to 
15
death certificates of veterans is collected, deter-
16
mined, and reported by the Department of Vet-
17
erans Affairs. 
18
(T) An assessment of any patterns appar-
19
ent to the National Academies of Sciences, En-
20
gineering, and Medicine based on the review 
21
conducted under paragraph (1). 
22
(U) Such recommendations for further ac-
23
tion that would improve the safety and well- 
24
being of veterans as the National Academies of 
25
23:56 Jan 20, 2021
H67
10 
•HR 67 IH
Sciences, Engineering, and Medicine determine 
1
appropriate. 
2
(3) COMPILATION OF DATA.— 
3
(A) FORM
OF
COMPILATION.—The Sec-
4
retary of Veterans Affairs shall ensure that 
5
data compiled under paragraph (2) is compiled 
6
in a manner that allows it to be analyzed across 
7
all data fields for purposes of informing and 
8
updating clinical practice guidelines of the De-
9
partment of Veterans Affairs. 
10
(B) COMPILATION
OF
DATA
REGARDING 
11
COVERED VETERANS.—In compiling data under 
12
paragraph (2) regarding covered veterans de-
13
scribed in subparagraphs (A) through (C) of 
14
such paragraph, data regarding veterans de-
15
scribed in each such subparagraph shall be 
16
compiled separately and disaggregated by year. 
17
(4) COMPLETION OF REVIEW AND REPORT.— 
18
The agreement entered into under paragraph (1) 
19
shall require that the National Academies of 
20
Sciences, Engineering, and Medicine complete the 
21
review under such paragraph and submit to the Sec-
22
retary of Veterans Affairs a report containing the 
23
results of the review not later than 180 days after 
24
entering into the agreement. 
25
23:56 Jan 20, 2021
H67
11 
•HR 67 IH
(b) REPORT.—Not later than 30 days after the com-
1
pletion by the National Academies of Sciences, Engineer-
2
ing, and Medicine of the review required under subsection 
3
(a), the Secretary of Veterans Affairs shall— 
4
(1) submit to the Committee on Veterans’ Af-
5
fairs of the Senate and the Committee on Veterans’ 
6
Affairs of the House of Representatives a report on 
7
the results of the review; and 
8
(2) make such report publicly available. 
9
(c) DEFINITIONS.—In this section: 
10
(1) The term ‘‘black box warning’’ means a 
11
warning displayed on the label of a prescription drug 
12
that is designed to call attention to the serious or 
13
life-threatening risk of the prescription drug. 
14
(2) The term ‘‘covered veteran’’ means a vet-
15
eran who received hospital care or medical services 
16
furnished by the Department of Veterans Affairs 
17
during the five-year period preceding the death of 
18
the veteran. 
19
(3) The term ‘‘first-line treatment’’ means a po-
20
tential intervention that has been evaluated and as-
21
signed a high score within clinical practice guide-
22
lines. 
23
(4) The term ‘‘State’’ means each of the States, 
24
territories, and possessions of the United States, the 
25
23:56 Jan 20, 2021
H67
12 
•HR 67 IH
District of Columbia, and the Commonwealth of 
1
Puerto Rico. 
2
Æ 
23:56 Jan 20, 2021
H67
